fda semaglutide decision US approves weight loss drug Wegovy to prevent cardiovascular events Minnesota doctor says FDA weight-loss

(2009) reviewed the role of glutathione depletion in various disease models, demonstrating that GSH:GSSG ratio disturbances are associated with oxidative stress across multiple organ systems in preclinical research [2]

Explore the full study to evaluate its impact on treatment algorithms and personalized care pathways: To view or add a comment, sign in New Evidence in Obesity Care A recent large-scale study from the Cleveland Clinic compared bariatric surgery with GLP-1 receptor agonists alone and the results are eye-opening: More sustained weight loss Greater reductions in cardiovascular risk Lower mortality rates This reinforces what many of us in the field have observed: Bariatric surgery isnt just about weight its about long-term health outcomes

In a statement released Monday, it claims that Hims has failed to adhere to the law which prohibits mass sales of compounded drugs under the false guise of personalization and are disseminating deceptive marketing that put patient safety at risk. Novo says its still open to working with telehealth companies so as long as they dont engage in illegal sham compounding, and it has existing agreements with other companies, like Ro, to sell its drugs

Often called the master antioxidant , glutathione plays a central role in defending your cells from oxidative stress, supporting detoxification , enhancing immune function , and promoting cellular repair all crucial during cold and flu season